Navigation Links
GeoVax Labs, Inc. Announces Results of 2009 Annual Shareholders Meeting
Date:6/23/2009

ATLANTA, June 23 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta-based biopharmaceutical company developing human vaccines for diseases caused by the HIV-1 (Human Immunodeficiency Virus), and other infectious agents, today announced the results of its Annual Shareholders Meeting, held on June 18, 2009.

During the meeting, shareholders re-elected seven nominees for directors of the company to serve until the 2010 Annual Meeting of Shareholders and until their successors are duly elected or appointed and qualified. They are: Donald Hildebrand, Andrew Kandalepas, Dean Kollintzas, Robert McNally, Harriet Robinson, John Spencer and Peter Tsolinas. Additionally, stockholders ratified the appointment of Porter Keadle Moore LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2009.

Don Hildebrand, company co-founder and Chairman of the Board of Directors, provided opening remarks at the meeting, highlighting significant progress over the past year. A few of the key advances presented included: GeoVax as being the only company currently conducting Phase 2a clinical trials for an AIDS vaccine in the U.S., excellent safety and immune responses being reported in five completed human trials, the advancement of plans to begin human therapeutic [treatment] trials in the U.S., stable corporate financial condition, rising recent stock price, substantial increase in the number of new investors in GeoVax, substantial press coverage and investor interest at the World BIO Conference in Atlanta, invitations to present GeoVax at various investor conferences and several scientific presentations and publications by Dr. Robinson in the U.S. as well as in Europe.

In addition to the business of the annual meeting, Robert McNally, president and chief executive officer, provided an overview of the company's progress, highlighting GeoVax's
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
2. GeoVax Labs, Inc. Comments on Discontinuance of Mercks HIV Vaccine Trial
3. Excellent Results Received from GeoVaxs Full-Dose HIV/AIDS Vaccine Trial
4. GeoVax Labs, Inc. Third Quarter Financial Results and Operational Update
5. GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel
6. GeoVax Labs, Inc. Selected by Georgia Bio as 2008 Deal of the Year Award Winner in Life Sciences Industry
7. Dr. Harriet Robinson Joins GeoVax Team as V.P. of R & D to Accelerate AIDS Vaccine Trials Program
8. GeoVax Vaccine Only 5th AIDS Vaccine Moving to Phase 2 Human Trials
9. GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2007 Financial Results
10. GeoVax Secures $10 Million Financing Commitment
11. GeoVax Reports Progress on Its AIDS Vaccine Technology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., DELFT,TheNetherlandsandJOHANNESBURG,November25...ionandPyxisDiscoveryannouncedtoday,thattheyhavesig...anies,services. , Pyxis,sworldclasscomputatio...dwithiThemba,sservicedivisiontoprovidemedicinaland...ughPyxis,internationalclientnetwork.iThembaPharma...
(Date:11/24/2009)..., PITTSBURGH,Nov.24/PRNewswire/-- ,, WHAT:Rom...rsfollowinganautoaccident,wasactuallyfullyconsciou...ingAmericasegment.TheDynaVoxEyeMaxwasfeaturedinthe...ndotherconditionscanunlockcommunication. ,, WHE...eonlineat www.dynavoxtech.com ,, WHO:Rom...
(Date:11/24/2009)..., SANDIEGO,Nov.24/PRNewswire-FirstCall/--AnadysP...atitwillpresentatthe21stAnnualPiperJaffrayHealthca...6:00a.m.PST).TheconferenceisbeingheldatTheNewYorkP...cutiveOfficerofAnadys,willprovideanoverviewofAnady.... ,, Thecorporatepresentationwillbesimultaneous...
Breaking Medicine Technology:iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Career Step and Kapi 26apos 3Bolani Community College Celebrate Five Year Partnership 55216 1Career Step and Kapi 26apos 3Bolani Community College Celebrate Five Year Partnership 55216 2R Tech Ueno Completes Subject Enrollment in Phase 2 Clinical Study of 0 15 25 UF 021 4888 1R Tech Ueno Completes Subject Enrollment in Phase 2 Clinical Study of 0 15 25 UF 021 4888 2JNCI news brief 3A Melanosome dynamics and sensitivity of melanoma cells to chemotherapy 55208 1
...nson & Johnson,will provide a pre-recorded webcast....m. (Eastern Time) to coincide with the American P...Phase 3 clinical data presentations on,investigati...ntrally acting,oral analgesic, will be presented f..., with the lead tapentadol researchers, will be,ma...
...ad to Individualized Treatment for ...ta presented today on,Vanda Pharmaceuticals Inc.,s...loperidone, included its 4-week, short-term Phase ...ong-term, 52-week trials, studying the efficacy,an...antagonist ("atypical"),antipsychotic currently un...
Other Medicine Technology:Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 2Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 3Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 4Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 5Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 6Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 7
(Date:11/27/2009)... vehicles may reduce future disease burden, resear... News) -- Encouraging city dwellers to walk and bi...er public health benefits than increased used of l... , The study compared the projected health effe...enarios for London, England, and Delhi, India: bu...
(Date:11/27/2009)...th™ announced today that Spectrum Health (Gr...nterprise orthopedic templating solution and its T... (PRWEB) November 27, 2009 -- Voyant He...Grand Rapids, Michigan) has licensed its TraumaCad... TraumaCad Extend workflow solution, to allow its ...
(Date:11/27/2009)...nteractive anatomy education apps from Modality an...sciences learning opportunities for iPhone and iPo...us) November 27, 2009 -- Modality, Inc. and Lipp... Wolters Kluwer Health, today announced the availa...App Store. Clemente’s Anatomy, Rohen’s...
(Date:11/26/2009)... Americans living with diabetes will nearly double...lion in 2034. Over the same period, spending on di...n to $336 billion, even with no increase in the pr...ersity of Chicago report in the December issue of ...etes covered by Medicare will rise from 8.2 millio...
(Date:11/26/2009)...motional rollercoaster, study finds , , ...fear factor meets the jubilant sports fan. , A ...hose who root for the winning team -- enjoy the gr...tch and victory was in doubt, producing feelings o...hanksgiving weekend as you,re glued to the TV set,...
Breaking Medicine News(10 mins):Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3
... discoveries and breakthroughs in biology, not jus...ntal molecular processes. Delegates at a recent re...e Foundation (ESF) and Wellcome Trust heard how te...omestic and farm animals for example, it is now po...
...loper of,advanced technology solutions for homelan...as entered into a new development and license opti...stics to develop diagnostic,sensors. The goal is t...systems. Under the terms of the agreement, ICx wi...
....CMELLC.com ), a,leading provider of fully accredi...78, today announced it has been granted five-year ...ation (APA) as an approved sponsor of,continuing m...approval system, which,recognizes organizations co...
...vered a way to use a simple blood test that may ac...hich gives little warning and is almost always fat...th in Public Library of Science (PLoS), represents...rough the chest. They can become huge without caus...
...have found that 73% of avian flu outbreaks in the ...rm, but larger outbreaks are more likely to involv...rsitys Faculty of Veterinary Science and Departmen...que levels of detail including contact points betw...
...nt Boost in Payments, According to a New Re...nn., Oct. 24 HealthLeaders-InterStudy, the,leadin...ports that the,nation,s largest pay for performanc...ns access to laboratory results,exclusively held b...
Other Medicine News:Health News:Not just humans benefit from animal biotechnology 2Health News:Not just humans benefit from animal biotechnology 3Health News:ICx Technologies and Siemens Medical Solutions Diagnostics Enter In Vitro Diagnostics Development and License Option Agreement 2Health News:CME LLC Granted Five-Year Full Approval by the American Psychological Association 2Health News:A new key to detecting deadly aortic aneurysms 2Health News:Large avian flu outbreaks more likely to involve duck meat industry, experts find 2Health News:California's Pay for Performance Breaks Ground With New Program Components 2
SoftTech Health Lab QMS (Quality Management System)
...perate and maintain. The units are sealed from the... which minimize the potential for airborne bacteri... two-, four-, and ten-bag capacities, the systems ...Line Thawing Systems are FDA-cleared to thaw plasm...
CytoTherm-DR (Dry Rocking)
CytoTherm-4S
Medicine Products: